Despite decades of research, and significant medical breakthroughs, cancer mortality rates remain high, while efficacious therapeutic options vary greatly across cancer types. This heterogeneity in effective treatment options is due in part to cancer’s ability to elude recognition by the immune system. As such, additional, novel approaches for harnessing the immune system are needed to…